Radius Health (RDUS) Misses Q4 EPS by 15c

Radius Health (NASDAQ: RDUS) reported Q4 EPS of ($1.59), $0.15 worse than the analyst estimate of ($1.44). Product revenue for the quarter came in at $7.66 million versus the consensus estimate of $7.03 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
• SuperCom (SPCB) Tops Q3 EPS by 43c